Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness |
| |
Authors: | Laura Sánchez-Tejada Ruth Sánchez-Ortiga Óscar Moreno-Pérez Carmen Fajardo Montañana Maria Niveiro Nicholas A Tritos Antonio M Picó Alfonso |
| |
Institution: | 1. Endocrinology Department, Research Unit, Hospital General Universitario Alicante, Alicante, Spain;2. Endocrinology Department, Hospital Universitario La Ribera, Spain;3. Department of Pathology, Hospital General Universitario Alicante, Alicante, Spain;4. Neuroendocrin Unit, Massachusetts General Hospital and Harvard Medical School, United States |
| |
Abstract: | Introduction and objectiveThe ability to predict recurrence of pituitary adenoma (PA) after surgery may be helpful to determine follow-up frequency and the need for adjuvant treatment. The purpose of this study was to assess the prognostic capacity of pituitary tumor transforming gene (PTTG), insulin-like growth factor 1 receptor (IGF1R), and Ki-67.Materials and methodsIn this retrospective study, the normalized copy number (NCN) of PTIG and IGF1R mRNA was measured using RT-PCR, and the Ki-67 index was measured by immunohistochemistry in 46 PA samples. Clinical data, histological subtype, and radiographic characteristics were collected to assess associations between variables and tumor behavior. Progression of tumor remnants and its association to markers was also studied in 14 patients with no adjuvant treatment after surgery followed up for 46 ± 36 months.ResultsExtrasellar tumors had a lower PTTG expression as compared to sellar tumors (0.065 1st–3rd quartile: 0.000–0.089] NCN vs. 0.135 0.105–0.159] NCN, p = 0.04). IGF1R expression changed depending on histological subtype (p = 0.014), and was greater in tumor with remnant growth greater than 20% during follow-up (10.69 ± 3.84 NCN vs. 5.44 ± 3.55 NCN, p = 0.014).ConclusionsOur results suggest that the IGF1R is a more helpful molecular marker than PTTG in PA management. Ki-67 showed no association to tumor behavior. However, the potential of these markers should be established in future studies with standardized methods and on larger samples. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|